A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral Therapy

SIMPLE SUMMARY: Mac-2 binding protein glycosylation isomer (M2BPGi) has not been used in a risk score to predict hepatocellular carcinoma (HCC). We enrolled 1003 cirrhotic patients receiving entecavir or tenofovir monotherapy to construct an HCC risk score. The ASPAM-B score, based on age, sex, plat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chien-Hung, Hu, Tsung-Hui, Wang, Jing-Houng, Lai, Hsueh-Chou, Hung, Chao-Hung, Lu, Sheng-Nan, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599873/
https://www.ncbi.nlm.nih.gov/pubmed/36291847
http://dx.doi.org/10.3390/cancers14205063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599873/
https://www.ncbi.nlm.nih.gov/pubmed/36291847
http://dx.doi.org/10.3390/cancers14205063

Ejemplares similares